Product Name: Tirzepatide
CAS Number: 2023788-19-2
Molecular Formula: C₂₂₅H₃₄₀N₆₀O₆₅
Molecular Weight: ~4,805 Da
Amino Acids: 39 amino acids
Synonyms: LY3298176, GLP-1/GIP receptor agonist, dual incretin agonist
Origin: Synthetic peptide via recombinant expression or solid-phase peptide synthesis (SPPS)
Advance your metabolic research with our Tirzepatide Liquid Pen, a high-purity dual GLP-1 and GIP receptor agonist peptide formulated in convenient liquid form for precision dosing in preclinical studies. Intended strictly for laboratory research, this ready-to-use pen format simplifies handling and supports consistent, controlled research protocols.
⚠️ For research use only. Not for human consumption. Not a drug or supplement.
🔬 Research Applications:
Tirzepatide is widely used in preclinical studies involving:
Weight loss and appetite regulation
Insulin resistance and glucose metabolism
Hormonal pathway modulation in obesity
Dual incretin signaling mechanisms
GLP-1 and GIP peptide receptor research
⚙️ Key Features:
Dual GLP-1/GIP receptor agonist
Supplied in a sterile, pre-filled liquid pen
No reconstitution required – ready to use for controlled lab dosing
Suitable for in vivo and in vitro research applications
COA and full documentation available
⚠️ Compliance Notice:
This product is intended exclusively for scientific research. It is not approved for human or veterinary use and should never be injected, ingested, or applied to any living being.
❗ For laboratory use only. Not for diagnostic or therapeutic purposes.
💼 Why Choose Our Tirzepatide Liquid Pen?
High-purity, lab-tested peptide in ready-to-use format
Cold-chain shipped for maximum stability
Trusted by academic institutions, CROs, and research teams
check_circle
check_circle
Comments (0)
Your review appreciation cannot be sent
Report comment
Report sent
Your report cannot be sent